Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
Saved in:
| Main Authors: | Victoria Larsson, Sara Hall, Kaj Blennow, Oskar Hansson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12370119/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01) -
The genetic regulation of protein expression in cerebrospinal fluid
by: Oskar Hansson, et al.
Published: (2022-12-01) -
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
by: Gemma Salvadó, et al.
Published: (2023-03-01) -
Cerebrospinal fluid protein profiling of inflammatory and neurobiological markers in Lyme neuroborreliosis
by: Sofie Haglund, et al.
Published: (2025-06-01) -
Cerebrospinal fluid β-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease--systematic review and meta-analysis.
by: Jin-A Mo, et al.
Published: (2015-01-01)